Researchers develop platform to identify cancer mutations that may be responsive to drug therapies

A Cleveland Clinic-led team of researchers has developed a personalized genomic medicine platform that will help advance accelerate genomic medicine research and genome-informed drug discovery, according to new study results published recently in Genome Biology.

Author:

Leave a Reply

Your email address will not be published. Required fields are marked *